Article ; Online: Elevated plasma α1-antichymotrypsin is a biomarker candidate for malaria patients.
2022 Volume 55, Issue 11, Page(s) 571–576
Abstract: Advancements in the field of proteomics have provided opportunities to develop diagnostic and therapeutic strategies against various diseases. About half of the world's population remains at risk of malaria. Caused by protozoan parasites of the genus ... ...
Abstract | Advancements in the field of proteomics have provided opportunities to develop diagnostic and therapeutic strategies against various diseases. About half of the world's population remains at risk of malaria. Caused by protozoan parasites of the genus Plasmodium, malaria is one of the oldest and largest risk factors responsible for the global burden of infectious diseases with an estimated 3.2 billion persons at risk of infection. For epidemiological surveillance and appropriate treatment of individuals infected with Plasmodium spp., timely detection is critical. In this study, we used combinations of depletion of abundant plasma proteins, 2-dimensional gel electrophoresis (2-DE), image analysis, LC-MS/MS and western blot analysis on the plasma of healthy donors (100 individuals) and vivax and falciparum malaria patients (100 vivax malaria patients and 8 falciparum malaria patients). These analyses revealed that α1-antichymotrypsin (AACT) protein levels were elevated in vivax malaria patient plasma samples (mean fold-change ± standard error: 2.83 ± 0.11, based on band intensities), but not in plasma from patients with other mosquito-borne infectious diseases. The results of AACT immunoblot analyses showed that AACT protein was significantly elevated in vivax and falciparum malaria patient plasma samples (≥ 2-fold) compared to healthy control donor plasma samples, which has not been previously reported. [BMB Reports 2022; 55(11): 571-576]. |
---|---|
MeSH term(s) | Animals ; Humans ; Malaria, Vivax/diagnosis ; Malaria, Vivax/epidemiology ; Malaria, Vivax/parasitology ; Plasmodium vivax ; Chromatography, Liquid ; Tandem Mass Spectrometry ; Malaria/drug therapy ; Malaria/epidemiology ; Malaria/parasitology ; Plasmodium ; Malaria, Falciparum/diagnosis ; Malaria, Falciparum/parasitology ; Biomarkers ; Communicable Diseases |
Chemical Substances | Biomarkers |
Language | English |
Publishing date | 2022-10-04 |
Publishing country | Korea (South) |
Document type | News |
ZDB-ID | 2410389-5 |
ISSN | 1976-670X ; 1976-6696 |
ISSN (online) | 1976-670X |
ISSN | 1976-6696 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 4202: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.